A Clark level IV melanoma means the tumor has grown into the reticular dermis, the thick, lower layer of your skin, and that depth does carry real clinical weight. In a large study of over 3,300 patients, five-year survival for Clark level IV was about 68%, compared with 95% for level II and 81% for level III. But that single number obscures a lot. Your prognosis depends on several factors working together, and Clark level alone tells your oncologist less than it once did.
What Clark Level IV Describes
Clark levels are an anatomic scale from I to V that describes how far down into the skin a melanoma has invaded. Level I is confined to the epidermis, the outermost layer. Level II reaches the papillary dermis, the loose connective tissue just beneath the epidermis. Level III fills the papillary dermis. Level IV pushes into the reticular dermis, a denser collagen-rich layer that sits deeper. Level V means the tumor has reached the subcutaneous fat beneath the skin entirely.
So Clark level IV sits near the upper end of the scale. It is not the worst possible depth, but it means the melanoma has moved well past the surface. The reticular dermis contains blood vessels and lymphatic channels, which is partly why deeper invasion raises the risk of the cancer spreading to lymph nodes or distant sites.
Survival Numbers and What They Actually Tell You
The most commonly cited five-year survival figures by Clark level come from a study of 3,323 patients tracked over two decades. Clark level II survival was about 95%, level III about 81%, level IV about 68%, and level V about 47%.1Cancer. Multivariate analysis of the relationship between survival and the microstage of primary melanoma by clark level and breslow thickness Those numbers make a Clark IV diagnosis feel serious, and it is. But these are population averages spanning a wide range of tumor thicknesses, ulceration statuses, and treatment eras. Your individual outlook can be meaningfully different from the average depending on what else your pathology report shows.
One example of how misleading the average can be: a separate study found that even within the Clark level IV category, there were gradations of tumor thickness that produced statistically different survival rates.2PubMed Central. A Multifactorial Analysis of Melanoma: Prognostic Histopathological Features Comparing Clark’s and Breslow’s Staging Methods A thin Clark IV tumor and a thick Clark IV tumor are genuinely different animals, even though they share the same level designation. This is one reason that modern staging relies on more than just Clark level.
Why Breslow Thickness Often Matters More
Breslow thickness measures the actual depth of the melanoma in millimeters, from the top of the epidermis to the deepest identifiable tumor cell. It is a continuous measurement rather than a categorical one, and it has consistently proven to be a stronger predictor of outcome than Clark level. The same multifactorial analysis that confirmed Clark level correlates with survival also found that tumor thickness was the more powerful predictor.2PubMed Central. A Multifactorial Analysis of Melanoma: Prognostic Histopathological Features Comparing Clark’s and Breslow’s Staging Methods
This distinction matters because two melanomas can both be Clark level IV but have very different Breslow measurements. The reticular dermis varies in thickness depending on where the melanoma sits on the body. On the back, it can be several millimeters deep; on the eyelid, it is razor-thin. A melanoma barely crossing into the reticular dermis on the back might measure 1.5 mm by Breslow, while a melanoma doing the same thing on the eyelid might measure 0.6 mm. Breslow captures that difference; Clark level does not.
This is why the American Joint Committee on Cancer (AJCC) has steadily moved away from Clark level in its formal staging system. In the 2009 revision, Clark level of invasion was replaced by mitotic rate as a primary criterion for defining higher-risk thin melanomas.3PubMed Central. Final Version of 2009 AJCC Melanoma Staging and Classification This was not arbitrary. The data showed that mitotic rate, which counts how actively the cancer cells are dividing, added more prognostic information than Clark level for tumors in the thin category.
Where Clark Level IV Still Changes Decisions
Despite its reduced role in formal staging, Clark level has not disappeared from clinical practice. It still shows up on pathology reports, and there are specific situations where a level IV reading directly affects what your doctors recommend.
The most important of these involves thin melanomas, those measuring 1 mm or less by Breslow. Most thin melanomas carry an excellent prognosis. But thin melanomas that are also Clark level IV appear to be an important exception to that rule. In one study, thin Clark level IV tumors had a five-year survival of roughly 59%, compared with about 97% for thin Clark level II and 94% for thin Clark level III tumors in the same thickness range.4PubMed Central. Thin level IV malignant melanoma. A subset in which level is the major prognostic indicator That is a dramatic gap. If you have a thin melanoma that happens to reach Clark level IV, the thickness measurement alone would underestimate your risk.
Clark level IV also influences decisions about sentinel lymph node biopsy (SLNB), the procedure that checks whether melanoma cells have spread to the nearest lymph nodes. In the major international Multicenter Selective Lymphadenectomy Trial, patients with any-thickness melanoma at Clark level IV or higher were eligible for SLNB.5PubMed Central. Sentinel Node Biopsy for Early-Stage Melanoma Accuracy and Morbidity in MSLT-I, an International Multicenter Trial A study of thin melanomas with mitotic activity found that those at Clark level IV or V had a sentinel lymph node positivity rate of about 8%, compared with roughly 3% for level II–III lesions.6PubMed Central. Clark Level Risk Stratifies Patients with Mitogenic Thin Melanomas for Sentinel Lymph Node Biopsy An 8% rate may sound small, but it is high enough for most oncologists to recommend the biopsy.
Current clinical guidelines generally recommend offering SLNB to patients with melanomas exceeding 0.8 mm in depth.7PubMed Central. Primary excision margins, sentinel lymph node biopsy, and completion lymph node dissection in cutaneous melanoma: a clinical practice guideline But for melanomas thinner than that cutoff, a Clark level IV finding can be the factor that tips the decision toward performing SLNB anyway, especially if mitotic activity is also present.
The Reproducibility Problem With Clark Level
One often-overlooked issue with Clark level is that pathologists do not always agree on it. Identifying the boundary between the papillary dermis and the reticular dermis under a microscope is a judgment call, and that judgment varies from pathologist to pathologist.
A study comparing specialist melanoma unit pathologists with non-specialist pathologists found that agreement on Breslow thickness was excellent, but agreement on Clark level was only moderate.8Annals of Surgery. Interobserver Variation in the Histopathologic Reporting of Key Prognostic Parameters, Particularly Clark Level, Affects Pathologic Staging of Primary Cutaneous Melanoma That moderate agreement led to disagreements in pathologic substaging for a meaningful fraction of cases. A separate study assessing observer agreement among experienced pathologists found that agreement on Breslow thickness was good, while agreement on Clark level was only fair.9American Journal of Clinical Pathology. Identification of Vertical Growth Phase in Malignant Melanoma: A Study of Interobserver Agreement A third study of thin melanomas confirmed the same pattern and noted that significant variation in Clark level assessment exists even between observers working with the same slides.10PubMed. Observer variation in the measurement of Breslow depth and Clark’s level in thin cutaneous malignant melanoma
This is worth knowing because if your report reads Clark level IV and you are borderline between III and IV, the reading is less rock-solid than the Breslow measurement on the same report. It does not mean the Clark level is wrong, but it does mean a second opinion from a specialist dermatopathologist is reasonable if the Clark level is the main factor driving a treatment decision, particularly for a thin melanoma where the distinction between III and IV changes whether SLNB gets recommended.
What Happens After a Clark Level IV Diagnosis
If your melanoma is Clark level IV and has not already been widely excised, the next step is almost always a wider local excision to ensure clear margins. For melanomas deeper than 2 mm, guidelines recommend 2-cm surgical margins around the biopsy site.7PubMed Central. Primary excision margins, sentinel lymph node biopsy, and completion lymph node dissection in cutaneous melanoma: a clinical practice guideline For thinner tumors, margins are narrower. This is outpatient surgery under local anesthesia in most cases.
If SLNB is recommended and comes back positive, the next conversation involves whether to do a completion lymph node dissection, where the remaining lymph nodes in that basin are removed, or to monitor the area with regular ultrasound instead. The trend in recent years has been toward surveillance with ultrasound rather than immediate full dissection, based on trial data showing similar survival outcomes with less surgical morbidity.7PubMed Central. Primary excision margins, sentinel lymph node biopsy, and completion lymph node dissection in cutaneous melanoma: a clinical practice guideline
For patients whose melanoma is staged at IIB or higher after surgery, adjuvant therapy, treatment given after surgery to lower the risk of recurrence, has become increasingly common. The current standard involves immune checkpoint inhibitors such as pembrolizumab and nivolumab, or targeted therapy with BRAF-MEK inhibitors for tumors that carry the BRAF mutation.11PubMed Central. Adjuvant Therapy for High-Risk Melanoma: An In-Depth Examination of the State of the Field In patients with resected stage IIB and IIC melanoma, adjuvant immunotherapy has been associated with a meaningful improvement in three-year overall survival.12Surgery in Practice and Science. Utilization and survival benefit of adjuvant immunotherapy in resected high-risk stage II melanoma Whether adjuvant treatment makes sense for you depends on your final pathologic stage, which takes into account not just Clark level but Breslow thickness, mitotic rate, ulceration, and lymph node status.
Body Site and Melanoma Subtype Add Another Layer
Not all melanomas behave the same way, and where a melanoma grows on the body can influence both how it presents and how it behaves at a given Clark level. Acral melanomas, those that arise on the palms, soles, and under the nails, tend to be diagnosed at more advanced stages. In a review of 185 acral melanomas, Clark level was one of five prognostic variables that significantly affected survival.13PubMed. Acral melanoma: a review of 185 patients with identification of prognostic variables A more recent multicenter analysis found that acral melanomas associated with a history of trauma were more likely to present at Clark level IV or V with ulceration and mitotic activity.14PubMed Central. Poor prognosis of early-stage acral melanoma with a history of trauma: a multicenter analysis of 468 patients
Melanoma subtype matters too. Nodular melanomas, which grow vertically from the start rather than spreading outward along the surface first, tend to reach deeper Clark levels and thicker Breslow measurements by the time they are caught. Over a 35-year period, superficial spreading melanomas have been increasingly diagnosed thinner and earlier, thanks to awareness campaigns and dermoscopy. Nodular melanomas have not shown that same improvement. Their median time from first notice to diagnosis is only about five months, compared with nine months for superficial spreading types, yet they still present thicker.15Wiley Online Library (Cancer). Changes in the presentation of nodular and superficial spreading melanomas over 35 years If your Clark level IV melanoma is the nodular type, your oncologist may weigh that when discussing follow-up intensity.
Clark Level Beyond Melanoma
Clark level originated in melanoma pathology, but the concept of depth of invasion matters in other skin cancers as well. For cutaneous squamous cell carcinoma, the AJCC staging system incorporates tumor thickness, level of invasion, and other high-risk features into its T classification for assessing risk.16PubMed Central. A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics The principle is the same: the deeper a skin cancer goes, the more access it gains to lymphatic and vascular routes for spread. If you see Clark level mentioned on a non-melanoma skin cancer report, the implications are similar in direction, though the specific survival data differ.
Searching for Answers and Managing Anxiety
If you are reading this article shortly after receiving a pathology report, you are far from alone in going online for information. Research has found that about a third of people diagnosed with melanoma report higher anxiety after searching the internet about their diagnosis, and those who are younger, female, or more highly educated are the most likely to search in the first place.17PubMed. Internet use and anxiety in people with melanoma and nonmelanoma skin cancer
Part of what drives that anxiety is encountering survival statistics without the context to interpret them. A five-year survival figure of 68% for Clark level IV sounds alarming, but it is a crude aggregate from decades of data that includes patients who received less effective treatments than what is available now. Immunotherapy and targeted therapy have substantially changed outcomes for higher-risk melanoma over the past decade. The number on the older survival curve does not represent the prognosis of someone diagnosed and treated in the current era.
The most useful thing you can do with your pathology report is bring it to a melanoma specialist, an oncologist or a dermatologist who treats melanoma regularly, and have them walk you through what your specific combination of findings means. Clark level IV is a meaningful data point. It is not a sentence. Its significance depends on thickness, mitotic rate, ulceration, sentinel node status, subtype, and increasingly, what treatments are options for you. Context turns a scary number into a plan.